8/7/2019 Microscopic MRI
1/28
Progress in Neurobiology 67 (2002) 393420
MR microscopy and high resolution small animal MRI:applications in neuroscience research
Helene Benveniste a,b,, Steve Blackband c,d
a Medical Department, Brookhaven National Laboratory, Building 490, 30 Bell Avenue, Upton, NY 11793, USAb Department of Anesthesiology, SUNY-SB Stony Brook, New York, NY, USA
c McKnight Brain Institute, University of Florida, Gainesville, FL, USAd The National High Magnetic Field Laboratory, Tallahassee, FL, USA
Received 13 February 2002; accepted 7 June 2002
Abstract
The application of magnetic resonance (MR) imaging in the study of human disease using small animals has steadily evolved over
the past two decades and strongly established the fields of small animal MR imaging and MR microscopy. An increasing number
of neuroscience related investigations now implement MR microscopy in their experiments. Research areas of growth pertaining to MR
microscopy studies are focused on (1) phenotyping of genetically engineered mice models of human neurological diseases and (2) rodent
brain atlases. MR microscopy can be performed in vitro on tissue specimens, ex vivo on brain slice preparations and in vivo (typically
on rodents). Like most new imaging technologies, MR microscopy is technologically demanding and requires broad expertise. Uniform
guidelines or standards of a given MR microscopy experiment are non-existent. The main focus therefore of this review will be on
biological applications of MR microscopy and the experimental requirements. We also take a critical look at the biological information
that small animal (rodent) MR imaging has provided in neuroscience research.
2002 Published by Elsevier Science Ltd.
Contents
1. Introduction . . . . . . . . . . . . . . . . . .. . . . . . . . . . . . . . . . . . .. . . . . . . . . . . . . . . . . . .. . . . . . . . . . . . . . . . . . .. . . . 394
2. Physical considerations in MRI . . . . . . . . . . . . . . . . . . .. . . . . . . . . . . . . . . . . . .. . . . . . . . . . . . . . . . . . .. . . . 394
2.1. Spatial resolution and signal-to-noise ratio . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 394
2.2. Morphology and image contrast . . . . . . . . . . . . . . . . . . .. . . . . . . . . . . . . . . . . . . .. . . . . . . . . . . . . . . . . 395
2.3. Temporal resolution and function . . . . . . . . . . . . . . . . .. . . . . . . . . . . . . . . . . . .. . . . . . . . . . . . . . . . . . . 396
2.4. When does MRI become MR microscopy? . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 396
2.5. Summary . . . . . . . . . . . . . . . . .. . . . . . . . . . . . . . . . . . .. . . . . . . . . . . . . . . . . . .. . . . . . . . . . . . . . . . . . .. . . 396
3. Structural neurobiology. . . . . . . . . . . . . . . . . . .. . . . . . . . . . . . . . . . . . .. . . . . . . . . . . . . . . . . . .. . . . . . . . . . . . 397
3.1. Neuroanatomy . . . . . . . . . . . . . . . . .. . . . . . . . . . . . . . . . . . .. . . . . . . . . . . . . . . . . . .. . . . . . . . . . . . . . . . . 397
3.1.1. In vitro versus in vivo imaging . . . . . . . . . . . . . . . . .. . . . . . . . . . . . . . . . . . .. . . . . . . . . . . . . . . 397
3.1.2. In vitro experimentsformalin-fixed specimens . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 398
3.1.3. Contrast agents for in vitro MR microscopy studies . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 4023.1.4. In vivo MR microscopypractical aspects . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 403
3.2. Brain atlases and neuroinformatics . . . . . . . . . . . . . . . . .. . . . . . . . . . . . . . . . . . .. . . . . . . . . . . . . . . . . . 404
3.2.1. Mouse brain atlases by MR microscopy . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 404
3.3. Anatomical phenotyping by MR microscopy . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 405
3.3.1. Morphometry. . . . . . . . . . . . . . . . .. . . . . . . . . . . . . . . . . . .. . . . . . . . . . . . . . . . . . .. . . . . . . . . . . . 406
Abbreviations: MRI, magnetic resonance imaging; rf, radio frequency; SNR, signal-to-noise ratio; CNR, contrast-to-noise ratio; BMAP, Brain Molecular
Anatomy Project; MAP, map atlas project; LONI, laboratory of neuroimaging; MCA, middle cerebral artery; CBF, cerebral blood flow; ADC, apparent
diffusion coefficient; ApoE, apolipoprotein E; MS, multiple sclerosis; EAE, experimental allergic encephalomyelitis; LPC, lysophospahtidylcholine; AD,
Alzheimers disease; fMRI, functional magnetic resonance imaging; BOLD, blood oxygen level-dependent Corresponding author. Tel.: +1-631-344-7006; fax: +1-631-344-2540.
E-mail address: [email protected] (H. Benveniste).
0301-0082/02/$ see front matter 2002 Published by Elsevier Science Ltd.
PII: S 0 3 0 1 - 0 0 8 2 (0 2 )0 0 0 2 0 -5
8/7/2019 Microscopic MRI
2/28
394 H. Benveniste, S. Blackband / Progress in Neurobiology 67 (2002) 393420
4. Pathology visualized by MR microscopy . . . . . . . . . . . . . . . . .. . . . . . . . . . . . . . . . . . . .. . . . . . . . . . . . . . . . 407
4.1. Stroke . . . . . . . . . . . . . . . . . . .. . . . . . . . . . . . . . . . . . .. . . . . . . . . . . . . . . . . . . .. . . . . . . . . . . . . . . . . . .. . . 407
4.1.1. Diagnostic studies . . . . . . . . . . . . . . . . . . .. . . . . . . . . . . . . . . . . . .. . . . . . . . . . . . . . . . . . .. . . . . 407
4.1.2. MR microscopy studies related to stroke pathophysiology . . . . . . . . . . . . . . . . . . . . . . . . . . 408
4.1.3. Therapeutic stroke studies . . . . . . . . . . . . . . . . . .. . . . . . . . . . . . . . . . . . .. . . . . . . . . . . . . . . . . . 410
4.2. Head injury . . . . . . . . . . . . . . . . . . .. . . . . . . . . . . . . . . . . . .. . . . . . . . . . . . . . . . . . . .. . . . . . . . . . . . . . . . . 410
4.3. Demyelinating diseases . . . . . . . . . . . . . . . . . . .. . . . . . . . . . . . . . . . . . .. . . . . . . . . . . . . . . . . . .. . . . . . . 410
4.4. Aging and dementia . . . . . . . . . . . . . . . .. . . . . . . . . . . . . . . . . . . .. . . . . . . . . . . . . . . . . . .. . . . . . . . . . . . 411
4.5. MR microscopy of brain tumors in rodents . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 412
4.6. Functional imaging studies in the rodent brain . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 413
5. Bridging in vitro and in vivo studies. . . . . . . . . . . . . . . . . . .. . . . . . . . . . . . . . . . . . .. . . . . . . . . . . . . . . . . . . 414
6. Conclusions . . . . . . . . . . . . . . . . .. . . . . . . . . . . . . . . . . . .. . . . . . . . . . . . . . . . . . .. . . . . . . . . . . . . . . . . . .. . . . . 414
Acknowledgements . . . . . . . . . . . . . . . . .. . . . . . . . . . . . . . . . . . .. . . . . . . . . . . . . . . . . . . .. . . . . . . . . . . . . . . . . . . 415
References . . . . . . . . . . . . . . . . . . .. . . . . . . . . . . . . . . . . . .. . . . . . . . . . . . . . . . . . .. . . . . . . . . . . . . . . . . . .. . . . . . . 415
1. Introduction
The application of magnetic resonance (MR) imaging in
the study of human disease using small animals began withthe inception of MR more than 25 years ago. Hansen et al.
published the first anatomically interpretable MR images of
a normal living rat body (Hansen et al., 1980) in 1980 and
thus laid the groundwork for the many MR applications in
small animals soon to follow. The earliest MR applications
using small animals in the study of human disease focused on
tumors (Damadian et al., 1976; Crooks et al., 1980; Hansen
et al., 1980; Davis et al., 1981; Henkelman et al., 198 7)
and sterile abscesses (Herfkens et al., 1981). This effort
was soon followed by studies on MR visualization of acute
stroke, stroke maturation and the testing of various inter-
ventions (Buonanno et al., 1982, 1983; Naruse et al., 1986;Sauter and Rudin, 1986, 1987; Sauter et al., 1988, 1989).
When reviewing the literature over the last two decades
it is clear that physicists, bioengineers and computer scien-
tists continuously improved imaging capabilities of the MR
instruments, which in turn drove bio-application studies for-
ward. On the other hand, biologists increasing demand for
non-invasive imaging technologies suitable to follow pro-
gression and/or regression of disease in small animals and
tissue specimens undoubtedly enforced the fields of small
animal MR imaging and MR microscopy. In the liter-
ature, the term small animal MR imaging is often used
interchangeably with MR microscopy, although strictly
speaking the two fields operate within different spatial res-
olution ranges. However, in the following we will continue
to use the term MR microscopy for all high resolution
MR imaging, although this particular expression usually
refers to images acquired with a resolution of less than
100m in at least one dimension.
Many excellent review articles have been written describ-
ing the evolving MR technology, MR physics and hard-
ware design for MR microscopy (Budinger and Lauterbur,
1984; Chance, 1989; Johnson et al., 1993; Blackband et al.,
1999). This review is not meant to copy or supplement this
plentiful literature. Instead we intend to focus on biological
applications of MRI using small animals such as rodents in
the study of human disease. As it would be impossible to
cover all disease processes thoroughly we choose to con-
centrate on diseases afflicting the central nervous system.We will take a critical look at the biological information
that small animal (rodent) MR imaging has provided in neu-
roscience research. The literature on neuroscience related
investigations involving small animal MR imaging spans a
wide range of research fields, however, a large part of the
review will be dedicated to discussing current and future ap-
plications in transgenic mice, targeted mutations (knockout
mice) and chemically induced mutations in mice. It is this
new research direction that now occupies many MR imaging
laboratories all over the world.
2. Physical considerations in MRI
2.1. Spatial resolution and signal-to-noise ratio
The spatial resolution in MRI depends on multiple factors
(Back et al., 1991; Callaghan et al., 1994) but a good first
approximation, appropriate for the context of this review,
depends primarily on (1) the magnetic field strength used, (2)
the size of the radio frequency (rf) detector coil, (3) the total
signal averaging time, (4) the abundance of the nuclei under
investigation, and (5) the contrast mechanism employed in
the image (Mansfield and Morris, 1982). In the following,it is assumed that signals from the hydrogen nuclei in water
are used to form the images. Following this, a few general
comments can be made:
(A) The signal-to-noise ratio (SNR) increases more than
linearly with magnetic field strength (Mansfield and
Morris, 1982), hence the continuing development of
stronger magnets for MRI. Compromising this SNR
improvement is the cost of the magnets, increased rf
power requirements, potential adverse effects of high
rf power and stronger fields on biological organisms
and increases in image distortions arising from inhomo-
8/7/2019 Microscopic MRI
3/28
H. Benveniste, S. Blackband / Progress in Neurobiology 67 (2002) 393420 395
Fig. 1. MR microimages of brain slices showing the tradeoff between spatial resolution and acquisition time. The left image has a resolution of
15m 15m 300m but took 14 h to obtain. The right image has a lower resolution of 120m 230m 300m giving improved SNR that
was traded for a reduction in acquisition time to 4.3 min. Figure reproduced with permission from Bui et al. (1998).
geneities. For the most part a particular user will have
access to a particular magnet and the field strength will
then be fixed.
(B) The SNR increases linearly as the coil size decreases
(Mansfield and Morris, 1982). For this reason, thespatial resolution achieved in a given imaging time is
increased on smaller samples (or at least using smaller
coils to image parts of large samples). Thus resolutions
of hundreds of microns achieved on objects the size of
humans can be improved to a few microns or at least
tens of microns on samples a few millimeters in size.
(C) For the most part, improving contrast in an image
results in a loss of SNR. For example, increasing TE to
obtain more T2 weighting results in signal loss since the
signal decays exponentially with increasing TE. In or-
der to maintain adequate SNR when contrast is required
thus requires ways of regaining the SNR loss and is
most often achieved by reducing the spatial resolution
a little.
Given these issues, once the magnet system has been
chosen and rf coil has been selected (usually optimized
to span the region of interest), then the spatial resolution
obtained using a particular contrast mechanism (imaging
sequence) is mainly determined by the total data acquisition
time. However, SNR only increases as the square root of
the imaging time, while the SNR decreases as cube root of
the isotropic spatial resolution. Fig. 1 illustrates the tradeoff
that can be made between imaging time and spatial reso-
lution in images of a hippocampal rat brain slice. Bear in
mind that increasing the averaging time is thus an expen-
sive way of improving the SNR. For example, halving the
isotropic resolution reduces the SNR by a factor of 8, and
thus to regain the SNR of the lower resolution will require
a 64-fold increase in the imaging time (i.e. to maintain a
constant SNR, then t 1/x6, where x is the linear dimension
of an isotropic voxel and t the imaging time).
Thus a 1 min image would take an hour at half the reso-
lution, and nearly 3 days to halve the resolution again, and
so on. These considerations are obviously important when
considering imaging studies on pathological samples where
scan times can be long or in vivo studies where short scan
times are desirable. Fine details in images require both spa-
tial resolution and sufficient SNR in order to discern them.
2.2. Morphology and image contrast
A MR image can be manipulated to yield either morpho-
logical or functional information. To assess morphology,
SNR and resolution are not enough if signal differences
do not exist between different structureswithout these
the image will be flat and featureless. Thus an adequate
contrast-to-noise ratio (CNR) is required to separate struc-
tures of interest. MR techniques are unique in that several
contrast mechanisms (e.g. T1, T2, diffusion, etc.) may be
employed by using different imaging sequences that con-
trol the degree of contrast that can be achieved (referred to
as the image weighting). Since the contrast mechanisms
arise from distinct physical processes they may be used to
elicit different kinds of contrast that may aid in the resolu-
tion of different features of the sample under examination.
The significance of CNR is illustrated in Fig. 2. The spatial
resolution of all images is 0.00024 mm3 and SNR is 60:1.
On the T2 and T2 images the hippocampus mold can be
clearly outlined while the granule cell layer is barely appre-
ciated as a faint bright v-shaped structure.1 In comparison,
the CNR of the diffusion image is superior to both T2 and
T2 images and several additional hippocampal substructures
are apparent.
On a given MR system, two different sets of MR parame-
ters might display the same anatomical structures differently
or visualize different structures all together. For example, inthe T2 image in Fig. 2, the granule cell layer is visible as
a bright v-shaped line. On the other hand on the diffusion
image a dark line is present in a location corresponding to
the mossy fiber pathway (Fig. 2). Varying the weighting in
an image controls the contrast, but to do so usually requires
a reduction in the SNRthe heavily weighted image may
offer better contrast but requires a reduction in the spatial
resolution to maintain adequate SNR. Often a combination
1 It is here assumed that the bright line represents the granule cell
layer. However, strictly speaking this can only be confirmed by means of
histopathological studies.
8/7/2019 Microscopic MRI
4/28
396 H. Benveniste, S. Blackband / Progress in Neurobiology 67 (2002) 393420
Fig. 2. Three MR microimages of the dorsal hippocampus from a formalin-perfusion fixed C57BL6/J mouse brain acquired at a spatial resolution
of 0.00024 mm3 (9.4T MR instrument, Duke Center for In vivo Microscopy). Three different MR contrast parameters have been used (T2, T2 and
diffusion). The SNR of the three images are 60:1. Note that the display of anatomical structures is dependent on MR contrast used. For example, the
granule cell layer can be appreciated as a faint brighter v-shaped line on T2- and T2-weighted images whereas the mossy fiber pathway is apparent
only on the diffusion image as a dark appearing band.
of MR images using different MR contrast will yield more
anatomical information than either one alone and an imag-
ing protocol often involves the collection of several image
types.
2.3. Temporal resolution and function
As described above, SNR, spatial resolution and CNR are
very important considerations for optimal imaging of tissue
morphology. However, as indicated by Fig. 1, this must be
tempered by the temporal requirements of the study. Aside
from consideration of the cost and access to the scanner
time, studies on pathological tissues can be relatively long,
and tens of hours are not uncommon. However, for in vivo
studies, or studies of dynamic processes and function, the
temporal resolution becomes a major constraint. Sick ani-mals may not tolerate prolonged (or multiple) anesthesia.
Studies of changes in the genesis of a variety of lesion types
will require differing temporal resolutions from minutes
to days. Some dynamic or functional processes (such as
contrast agent uptake or blood flow measures) may require
imaging on the second or subsecond timescale. Cardiac
imaging may also require subsecond imaging techniques.
In all cases, the SNR requirements are exacting and usually
maintained by reducing the spatial resolution.
2.4. When does MRI become MR microscopy?
The delineation between high resolution MRI, small
animal MR imaging and MR microscopy is somewhat
unclear. Definitions for MR microscopy being images with
a resolution of less than 40100 m have been suggested
(Aiken et al., 1995) but are confounded by the number of
dimensions this refers to. For example, the slice width in
MR images is often considerably larger than the in-plane
resolution in order to improve SNR with little compromise
in image quality, taking advantage of some degree (Aiken
et al., 1995) of at least 1D symmetry in many samples (an
analogous situation occurs with optical techniques where
the slice width is the thickness of the section and often
much greater than the in-plane resolution). As suggested by
Aiken et al. (1995), we shall loosely refer to imaging with a
resolution of less than 100m in at least one dimension as
MR microscopy, and imaging above that as high resolu-tion MRI. Generally, the SNR in small animal MR images is
high enough to support the microscopy regime, making MR
microscopy and small animal imaging generally accepted
as synonymous. As indicated in the earlier sections, it is im-
portant not to become fixated with spatial resolution since
SNR, contrast and temporal resolution are as important in
terms of how useful the information content of the study
will be, and thus we consider the term MR microscopy as
indicative of microscopic resolutions, but more a matter of
semantics.
2.5. Summary
Multiple factors control the spatial resolution, SNR and
CNR in MR imaging, and in the above a few of the ma-
jor ones were discussed. Clearly, tradeoffs between spatial
resolution and imaging time are required to obtain the re-
quired contrast and/or functional information. In particular,
the size of the sample and whether the sample is in vivo or
ex vivo are major issues with respect to brain imaging. At
the extremes of present techniques and technology, resolu-
tions of tens of microns can be obtained on small samples
(millimeters to a few centimeters at most) with small coils
in many hours, while resolution of over hundreds of mi-
crons can be obtained in vivo on larger samples in minutes.
Between these extremes are a range of resolutions (spatial
and temporal) mediated by contrast and dynamic/functional
requirements. Many other factors contribute to the appear-
ance of MR images and will not be discussed in detail
here. For example, MR physical variables, such as T2 and
T1 are magnetic field dependent, and thus a given set of
MR parameters used on a low field MR system might yield
different CNR compared to that obtained on a high-field
MR system. Some of these will be alluded to in the rest
of this review and we must leave the reader to further
investigate.
8/7/2019 Microscopic MRI
5/28
H. Benveniste, S. Blackband / Progress in Neurobiology 67 (2002) 393420 397
3. Structural neurobiology
The term structural neurobiology covers several topics.
First, the ability to visualize normal as well as abnormal
neuroanatomy appears to be one of the most prominent and
important applications of the MR microscopy technology
in neuroscience research. Interestingly, research focusedon optimizing the visualization of rodent neuroanatomy
by MR microscopy has developed into separate fields of
brain atlas generation, neuroinformatics and associated
morphometry. Another newly evolving imaging concept is
anatomical phenotyping, which specifically focuses on how
MR microscopy can be used to anatomically characterize or
even screen for relevant pathology in genetically engineered
mice models of disease.
3.1. Neuroanatomy
From a neurobiologist point of view, MR microscopy
images of the rodent brain should capture structural infor-mation suitable to answer the questions of interest. Thus,
for some studies gross anatomical (surface, shape) infor-
mation will suffice while again others will require spatial
resolution at micro-anatomical (tissue architecture) or at the
single cell level. It is fair to conclude that gross anatomical
resolution can be routinely achieved by MR microscopy
in vivo as well as in vitro. However, in regards to tissue
architectural information in vivo data provide insufficient
anatomical information in most brain regions in spite of
technological advances. For example, in 1980 when Hansen
et al. first published in vivo images of the rat brain at a spa-
tial resolution of 0.33mm0.33mm8.4 mm, it appearedas a white homogeneous structure with no anatomical detail
(Hansen et al., 1980). Some years later, Johnson et al. im-
plemented improved MRI hardware for microscopy and
more efficient pulse sequences and produced high-quality
images of a living rat brain at a spatial resolution of
0.05mm 0.05mm 1 m m (Johnson et al., 1987). On
these images several subregional brain structures, such as
the corpus callosum, hippocampus and caudate nucleus
could be identified, however, cell layers could not be clearly
recognized (Johnson et al., 1987, 1986; Rudin, 1987). Sim-
ilar anatomical results were obtained in the living mouse
brain at a spatial resolution of 0.1 mm 0.2 mm 0.9 mm
(Munasinghe et al., 1995) and 0.058mm 0.058mm
0.469mm (McDaniel et al., 2001). In vivo images of the
canary brain were recently acquired at an even higher spa-
tial resolution of 0.078 mm 0.078mm 0.058mm (Van
der Linden et al., 1998). Interestingly, several brainstem
nuclei could be identified on the proton density-weighted
MR images (Van der Linden et al., 1998).
MR microscopy performed on formalin-fixed brain spec-
imens yields far more anatomical information compared
to in vivo for a number of reasons (to be discussed in the
Section 3.1.1). Fig. 3 shows a volume-rendered diffusion-
weighted 3D MRI data set acquired at a spatial resolution
of 2.4 104 mm3. The specimen is a formalin-perfusion
fixed C57BL6/J mouse brain. The 3D rendered forebrain
can be seen in the upper left corner (A) as well as tissue
architectural detail at three different levels (cf. Fig. 3EG).
Although several subregions within the hippocampus can
be appreciated, the spatial resolution, SNR and CNR of the
images presented in Fig. 3 clearly do not support visualiza-tion of single cells within individual cell layers. Structural
information in large single L7 neuronal cells from the ab-
dominal ganglia of sea hares (diameter of 300400 m) has
been obtained using specialized microcoils (Schoeninger
et al., 1994; Grant et al., 2001). However, at present this
has not been achieved in the intact animal or body organ
where the sample is larger and the cells within it smaller.
3.1.1. In vitro versus in vivo imaging
When assessing anatomical MR imaging data, it is im-
portant to distinguish between data acquired in vitro and
in vivo. For example, imaging of tissue specimens, that is,
formalin-perfusion fixed whole brains, fresh brain tissue orimmersion fixed brain tissue confers the experimenter sev-
eral advantages when compared to in vivo imaging. First,
overall scan times can be much longer in vitro (1050 h)
than in vivo (typically 30 min to 4 h per scan), which results
in better SNR for any given voxel size due to more signal
averaging as discussed previously (cf. Section 2). Second, in
vitro samples are obviously motionless, which also enhances
SNR for any given imaging protocol compared to in vivo
imaging; breathing and cardiac activity in the living animal
cause pulsatile physical excursions of up to several mil-
limeters in the brain, which significantly reduces the SNR
if not controlled for during the image acquisition (Hedlundet al., 1986, 2000a). Thirdly, the formalin-perfusion process
chemically alters tissue characteristics so that the CNR in
the MR images changes compared to that of living tissue
(vide infra). Additionally, the sample may often be shaped
(cut down) to fit optimally within the rf coils for optimal
SNR.
To begin to understand differences between in vitro and
in vivo MR imaging one must first compare an image ob-
tained in a living animal with one obtained post-mortem
using the exact same imaging parameters. Fig. 4 shows
two diffusion-weighted MR images of a C57BL6/J mouse
brain acquired at a spatial resolution of 0.058 mm
0.058mm0.46875 mm and a scan time of 2 h and 43 min.
Image A was acquired while the C57 mouse was alive and
B is a post-mortem acquisition of the same mouse (same
body temperature as A). The SNR of image B obtained
post-mortem has improved by 30% compared to image A
secondary to the arrest of physiological motion (breathing,
cardiac activity and/or cerebro-spinal fluid convective flow)
and ischemia-induced increases in the diffusion-signal (cf.
Section 4.1). The first question to ask is whether the SNR
improvement of image B also enhances its CNR (more accu-
rately referred to as a signal difference to noise (SNR))
when compared to image Ai.e. are more structures visible
8/7/2019 Microscopic MRI
6/28
398 H. Benveniste, S. Blackband / Progress in Neurobiology 67 (2002) 393420
Fig. 3. A volume-rendered diffusion-weighted 3D MR data set acquired at a spatial resolution of 2.4 104 mm3 on a 9.4T MR instrument (Duke
Center for In vivo Microscopy). The specimen is a formalin-perfusion fixed C57BL6/J mouse brain. (A) 3D rendered forebrain with three attachedsegmentation planes (BD). (B) Coronal diffusion-weighted MR image at the level of the caudate putamen and globus pallidus. The two nuclei are clearly
visible because the globus pallidus appears darker (see details in (E)). (C and D) Coronal images at the level of the hippocampus. Several hippocampus
subregions are apparent (see details in (F) and (G)).
in image B? Clearly, the most striking difference between
image A and B is the partial obliteration of the lateral and
third ventricle spaces post-mortem secondary to swelling
of the tissue. The black appearing ventricle system actually
confers contrast-to-noise ratios in the in vivo image A facil-
itating definition of several subregions compared to image
B. Thus, in this particular example, the increase in SNR
did not provide significantly more anatomical information
because the CNR did not improve in parallel.
3.1.2. In vitro experimentsformalin-fixed specimens
The advantage of imaging formalin-fixed specimens are
several-fold: (1) the specimens do not undergo autolysis over
time, can be preserved for years and scanned repeatedly; (2)
8/7/2019 Microscopic MRI
7/28
H. Benveniste, S. Blackband / Progress in Neurobiology 67 (2002) 393420 399
Fig. 4. Diffusion-weighted MR microimages (horizontal imaging plane, spatial resolution: 58 m58m470m, 7.1 T MR instrument, Duke Center for
In vivo Microscopy) from a C57Bl6/J mouse brain acquired in vivo (A) and post-mortem (B). The signal-to-noise ratio has increased by 30% in image
B secondary to arrest of physiological motion and ischemia-induced increases in the overall signal intensity. The SNR improvement in B compared
to A does not automatically lead to enhanced visualization of anatomical structures because the contrast-to-noise ratio has not improved in parallel.
8/7/2019 Microscopic MRI
8/28
8/7/2019 Microscopic MRI
9/28
H. Benveniste, S. Blackband / Progress in Neurobiology 67 (2002) 393420 401
Fig. 5. The effect of air entrapment within the imbedding material used for MR microscopy of tissue specimens is shown. Three large air bubbles have
formed on the dorsal surface of the tissue specimen, which can be seen as dark circular objects in the volume-rendered image (A). The air bubbles cause
large susceptibility artifacts, which obscure anatomical structures and therefore destroys the MR image (B).
etc.) and are affordable. Drawbacks include processing time
and the potential for entrapment of air within the medium,
which causes image artifacts. Further, samples immersed
in agarose gels need to be quickly removed after imaging,
cleaned and restored in formalin to prevent dehydration as
the gelling agars tends to dry out over time. Polyethylene
film and soaked gauzes are easy to use techniques that will
prevent dehydration of specimens at least for shorter periods
of time (probably 24h). However, a given specimen will eventually dry out if stored for
long period of times in Fomblin.
8/7/2019 Microscopic MRI
10/28
402 H. Benveniste, S. Blackband / Progress in Neurobiology 67 (2002) 393420
from the producers (Ausimont USA) and the consequent
considerable expenditure involved. Fluorocarbon (Fluo-
rinert) is another less expensive option, which seems to be
working just as well (Dhenain et al., 2001).
3.1.3. Contrast agents for in vitro MR microscopy studies
Paramagnetic contrast agents can be used to improvetissue discrimination in MR images when intrinsic CNR be-
tween structures is lacking. Contrast agents include chelates
of paramagnetic ions, both ionic and non-ionic, which gen-
erate both T1 and T2 effects (Brasch, 1983, 1992). Short-
ening the T1 results in an increase and shortening the T2
in a decrease of signal intensity (see review by Kroft and
de Roos, 1999). For example, intravenous administration
of gadolinium diethylenetriaminepentaacetic acid complex
(Gd-DTPA) will cause intact vessels to appear bright on
T1-weighted MR images. Several different paramagnetic
contrast agents exist, each characterized by their molec-
ular weights, viscosity, pharmacodynamic parameters and
Fig. 6. The effect of adding a contrast agent (Gd-DTPA) to the formalin fixation medium is shown. Without contrast enhancement the T2-weighted
MR microimage displays a limited number of anatomical structures (top image). The contrast-enhanced MR T2-weighted image provides superior
visualization of several hippocampal subregions (bottom image).
pharmacokinetic parameters (Runge, 1999; Kuriashkin and
Losonsky, 2000; Torchilin, 2000).
In vivo, the available contrast agents will not pass the
intact blood brain barrier (BBB); however, this problem
can be circumvented by administering them (a) intrathe-
cally, (b) into areas/structures without a BBB or (c) directly
into the brain parenchyma. For example, a 1:40 dilutionof Gd-DTPA:0. 9% NaCl administered intrathecally was
used to visualize positioning of spinal catheters in live rats
(Benveniste et al., 1999) and also enhanced visualization of
individual nerve roots (Benveniste et al., 1998). In another
study, a dilution of MnCl2 was administered into the olfac-
tory epithelium in living anesthetized rats via the naris and
directly into the aqueous humor of the eye (Pautler et al.,
1998). Twenty-four hours later, the presence of Mn2+ was
demonstrated in the olfactory pathway or the optic tract on
T1-weighted MR images indicating anterograde transport
of the tracer (Pautler et al., 1998). Jacobs and Fraser (1994)
injected single frog blastomeres with a covalent conjugate
8/7/2019 Microscopic MRI
11/28
H. Benveniste, S. Blackband / Progress in Neurobiology 67 (2002) 393420 403
of dextran with diethylenetriaminepentaacetic acid chelated
to Gd to follow embryogenesis. By means of repetitive
imaging, they were able to follow over time the migration
of contrast-enhanced cell clusters in the developing blas-
tomeres during gastrulation and neurulation (Jacobs and
Fraser, 1994; Ahrens et al., 1998b).
To enhance the CNR in high resolution MR images oftissue specimens and isolated body organs, paramagnetic
contrast agents have been added to the formalin fixation
medium (Johnson et al., 1993; Mellin et al., 1994; Smith
et al., 1994, 1996; Benveniste et al., 2000). For example,
Smith et al. injected bovine serum albumin coupled to
DTPA-Gd dissolved in 1% gelatin into the umbilical vein of
mouse embryos to augment anatomical visualization (Smith
et al., 1994). Using this technique, Smith et al. completed
a digital atlas that contains magnetic resonance images
of normal mouse embryos from 9.5 days after conception
to the newborn (Mellin et al., 1994; Smith et al., 1999);
http://embryo.soad.umich.edu/animal/bradresearch / bradre-
search.html). The digital MR microscopy embryology atlasseries include surface views as well as cross-sectional views
from the transverse, coronal, and sagittal planes for each
embryo and are also organized as a reference for researchers
studying embryological anatomy.
The addition of gelatin to the macromolecular contrast
agent fixation media allowed for greater than normal image
contrast due to intravascular retention of the contrast agent
(Smith et al., 1994). Without the addition of gelatin, the
contrast/formalin solution diffuses out of the intravascular
compartment into the interstitial and intracellular compart-
ments and reduces the CNR in the image (Benveniste et al.,
2000).The addition of Gd-DTPA to formalin-perfusion fixation
media has also been used to enhance visualization of tissue
architecture in the C57BL6/J mouse brain (Benveniste et al.,
2000). Figs. 6 and 7 show the effect of 1:40 (v/v) Gd-DTPA:
formalin on the CNR in the T2-weighted image. Without
contrast enhancement only the hippocampal outline and the
granule cell layer can be seen within the hippocampus region
(Fig. 6A); however, several hippocampal subregions are re-
vealed by the addition of contrast probably due to regional
differences in vessel density (Benveniste et al., 2000).
3.1.4. In vivo MR microscopypractical aspects
For the reader to truly appreciate the multidisciplinary
expertise involved in small animal in vivo MR microscopy
studies (Section 4), we will briefly review some of the tech-
nical requirements involved. First, the successful outcome
of any MRI experiment involving live animals is dependent
on a team of investigators. The MR physicist, bioengineers,
computer scientists, and MR instrument operator, together
with the biologist/physiologist must carefully plan all prac-
tical aspects of the experiment. The anesthesia, physiolog-
ical monitoring and gating requirements, that is, image
acquisition triggered by cardiac and/or ventilation (Hedlund
et al., 1986, 2000a,b; Johnson et al., 1993) must be addressed
Fig. 7. MR microimage of a single neural cell, the L7 cell from the ab-
dominal ganglia of the sea slug Aplysia californica. The spatial resolution
is 20m 20m 100m. The image shows a bright central nucleus
surrounded by dark cytoplasm, in turn surrounded by artificial seawater.
Reprinted by permission from Schoeniger and Blackband (1994).
as well as the expected length of the imaging sequence.3
The latter is important in regards to choice of anesthesia,
hydration requirements, and propensity for animal survival.
Table 2 presents a list of anesthetic agents, which have been
and continue to be used in various in vivo MR studies on
rodents. There is no right or wrong in regards to selec-
tion of anesthetic agents as long as (1) the compounds ful-
fill their main goal, that is, provide the animal relief of pain
and discomfort during the procedures and (2) the anesthetic
agent does not interfere with the goals of the study. The
latter has proven to be a problem in certain functional MR
imaging studies (Prichard et al., 1995; Yang et al., 1996).
For example, in two studies involving somatosensory activa-
tion, inhalational anesthesia (enflurane and halothane) was
replaced with -chloralose during this particular part of the
study (Gyngell et al., 1996; Yang et al., 1996). In a recent
study, it was also shown that anesthetic agents often used
in MR microscopy studies affect cerebral perfusion differ-ently (Hendrich et al., 2001). Another concern is the choice
of anesthetic agent for survival studies. Although relatively
few longitudinal rodent MR microscopy studies have been
published, it appears that inhalational agents are preferred
probably because they are easy to administer, rapidly ad-
justable and inexpensive (Wood et al., 2001).
3 The quantitative impact of cardiac gating and scan-synchronous venti-
lation on SNR and CNR in brain studies is not known. In most live animal
brain studies a stereotaxic frame immobilizes the head of the rodent and
images are not routinely acquired with cardiac and/or scan-synchronous
ventilation.
http://embryo.soad.umich.edu/animal/bradresearchprotect%20kern%20+.1667emelax%20/protect%20kern%20+.1667emelax%20bradre-search.htmlhttp://embryo.soad.umich.edu/animal/bradresearchprotect%20kern%20+.1667emelax%20/protect%20kern%20+.1667emelax%20bradre-search.htmlhttp://embryo.soad.umich.edu/animal/bradresearchprotect%20kern%20+.1667emelax%20/protect%20kern%20+.1667emelax%20bradre-search.html8/7/2019 Microscopic MRI
12/28
404 H. Benveniste, S. Blackband / Progress in Neurobiology 67 (2002) 393420
Table 2
Anesthetic agents used in MR imaging studies on rodents
Species Agent Route of administration Reference
Mice Halothane and N2O Inhalational Zaharchuk et al. (1997)
Pentobarbital Intraperitoneal Atlas et al. (1990), Huang et al. (1996)
Isoflurane Inhalational van Bruggen et al. (1999)
Rats Halothane Inhalational Benveniste et al. (1991), MacFall et al. (1991), Benveniste et al.,1992, van Bruggen et al., 1992, Beaulieu et al. (1993), Verheul et al.
(1993), Jiang et al. (1994), Lo et al. (1994), Roussel et al. (1994),
Busch et al. (1996), Rother et al. (1996), Jiang et al. (1997)
Isoflurane Inhalational Minematsu et al. (1992), Latour et al. (1994), Hasegawa et al.
(1995), Mancuso et al. (1995), Hall et al., 1996, Porszasz et al.
(1997), Qiu et al. (1997), Benveniste et al. (1999, 2000),
Miyasaka et al. (2000)
Chloralose Intravenous, intraperitoneal Gyngell et al. (1996), Yang et al. (1996)
Ketamine and pentobarbital Intramuscular, intraperitoneal Buonanno et al. (1983)
Diazepam fluanisone and fentanyl Intraperitoneal, intramuscular Verheul et al. (1992)
Pentobarbital urethane Intraperitoneal, subcutaneously Takahashi et al. (1993)
Pentobarbital Intravenous, intraperitoneal van Nesselrooij et al. (1989), Ford et al. (1990), Ogawa et al.
(1990), Hanstock et al. (1994)
N2O/O2 MSO4 Inhalational, subcutaneously Prichard et al. (1995)
Xylazine and ketamine Intravenously van de Vyver and Peersman (1990), Ford et al. (1990)
Gerbils Pentobarbital Not reported Kato et al. (1986)
The requirement for physiological monitoring and manip-
ulation of physiological parameters is obviously dependent
on study design. However, as a minimum requirement body
temperature, heart rate/ECG and respiratory rate of the ani-
mal need to be continuously monitored while the animal is
unapproachable in the magnet bore. Heart and respiratory
rates are essential to monitor in order to indirectly assess and
adjust anesthetic depth and for experiments requiring venti-
lation synchronous scanning and cardiac gating. Obviously,maintaining a normal body temperature is important for all
in vivo studies unless hypothermia is a requirement (Jiang
et al., 1994). For survival studies it is probably better to ad-
here to minimally invasive monitoring devices so as to assure
the lowest morbidity and mortality of the study groups. Lim-
ited information is currently available on the subject of mor-
tality in live animal MR studies as this parameter is rarely
reported in the literature. However, with the increase in use
of sick, immune deficient and overall physically fragile ge-
netically engineered mice in MR imaging studies, it will be
important to gather more general knowledge in this area.
3.2. Brain atlases and neuroinformatics
The Brain Molecular Anatomy Project (BMAP) is an
ongoing multi-institute NIH initiative that supports research
on the genomics of the nervous system with an initial effort
dedicated towards the study of gene expression patterns in
mouse and human brains (for more information, see http://
www.nimh.hih.gov/research/brainatlas.cfm). In lieu of this
initiative, a demand for interoperable databases and as-
sociated data management capable of extracting, storing,
fitting and displaying spatially distributed gene ex-
pression patterns into the human and rodent brain have
developed. Within the neuroinformatics community, such
multi-dimensional databases are often broadly referred to as
brain atlases or multi-dimensional atlases (Ghosh et al.,
1994; Dhenain et al., 2001; see also http://embryo.soad.
umich.edu/animal/bradResearch/bradResearch.html). The
ideal brain atlas database would not only serve as an
anatomical standard against which data can be compared
but also function as a management system of data. Thus, the
atlas needs to be digitally manipulative and freely availableon the World Wide Web. To function properly it should be
equipped with (1) a common coordinate system, (2) anatom-
ical labels for all the atlas elements (defined by the spatial
resolution of the images), (3) computational tools/algorithms
to allow the user to spatially map any given type of data
into the normalized atlas reference space, graphic interfaces
and querying approaches, (4) provided with systems for
information retrieval, biological modeling and simulation
and (5) links to all other relevant databases (for more detail,
see http://www.nimh.nih.gov/neuroinformatics/).
3.2.1. Mouse brain atlases by MR microscopy
As discussed, MR microscopy certainly has the capa-
bility to visualize mouse brain anatomy in sufficient detail
to be used to produce atlas templates for standardization,
mapping of histological data, gene expression patterns,
and functional imaging activation studies and for general
data retrieval. For this particular purpose, non-invasive MR
imaging data would seem superior to both cryo- and con-
ventional histological technologies because the data output
is naturally 3D. Further, the 3D MR data can be acquired
in an isotropic format so that any given slice plane can
be obtained without loss of structural information due to
zero-filling. The latter is important for general accuracy of
http://www.nimh.hih.gov/research/brainatlas.cfmhttp://www.nimh.hih.gov/research/brainatlas.cfmhttp://www.nimh.nih.gov/neuroinformaticshttp://www.nimh.nih.gov/neuroinformaticshttp://embryo.soad.umich.edu/animal/bradResearch/bradResearch.htmlhttp://embryo.soad.umich.edu/animal/bradResearch/bradResearch.htmlhttp://www.nimh.hih.gov/research/brainatlas.cfmhttp://www.nimh.hih.gov/research/brainatlas.cfm8/7/2019 Microscopic MRI
13/28
H. Benveniste, S. Blackband / Progress in Neurobiology 67 (2002) 393420 405
computational algorithms because it is important to preserve
as many landmarks (including accurate surface reconstruc-
tion) as possible when mapping, fitting and warping
other modality images into the atlas template.
Traditionally rodent brain atlases are made from histo-
logical processed brain sections, i.e. Nissl-stained sections
or cryo sections (Sidman et al., 1971; Slotnik and Leonard,1975; Pellegrino et al., 1979; Paxinos and Watson, 1982;
Franklin and Paxinos, 1997). Although this type of data
is 2D, it is actually possible to reconstruct 3D atlases
from cryo data because the input data from post-mortem
cryosectioning are digital images of the cryo-planed spec-
imen block face and are therefore already registered data
(Toga et al., 1994a,b). Nevertheless, cryo data does not
yield much anatomical information as the cryosections are
unstained and therefore do not serve as an ideal template to
use in regards to mapping and retrieval of anatomical in-
formation. Conventional stained histological brain sections
by definition provide the best visualization of neuroanatom-
ical structures. However, attempts to utilize histologicalmaterial for digital 3D reconstructions have often failed
due to (a) non-contiguous slice data sampling, (b) spatial
inconsistencies, and (c) artifacts caused by the histologi-
cal processing (staining and slide mounting). Nevertheless,
several initiatives are underway, which appear promising
(http://www.hms.harvard.edu/research/brain/).
A 3D digital MR microscopy atlas of a neonate mouse
lemur (primate Microcebus Mimurinus) cadaver head at
60m cubic voxel was produced in 1994 (Ghosh et al.,
1994). The images from this atlas display gross anatom-
ical structures as well as some micro-anatomy. This MR
microscopy atlas, however, has not been attached to a ref-erence space and coordinates for brain structures cannot
be obtained (Ghosh et al., 1994). Currently, there are only
two digital web based digital mouse brain atlases that are
based on MR microscopy data. The mouse atlas project
(MAP) out of the laboratory of neuroimaging (LONI) dis-
plays adult C57Bl6/J mouse brain anatomy and consists
of four different image modalitiesNissl-stained brain
sections, MR microscopy data, cryo data and labeled sec-
tions (http://www.loni.ucla.edu/MAP). Although this atlas
is still under development, it already has multiple elegant
functions. The interactive 2D viewer allows the user to
examine mouse brain data (four different modalities) in
three different imaging planes. Each of the data modali-
ties provides alternate anatomical information, that is, the
MR data sets display white matter particularly well while
the Nissl-stained brain data shows cell bodies/cell layers.
Several desirable functions are still under development
for example, labeling of structures when activating voxels
on individual images, links to same structures on other
modality images, etc. However, other MAP tools are avail-
able and include the 3D viewer and segmentation software,
which can be downloaded, explored and utilized. Proba-
bly the LONI MAP project is the most advanced digital
web based neuroinformatics tool available for mice data.
Another mouse brain atlas website is the atlas of the devel-
oping mouse brain (http://mouseatlas.caltech.edu/13.5dpc/)
produced by Dhenain, Ruffins and Jacobs out of the Bio-
logical Imaging Center at CalTech (Dhenain et al., 2001).
This atlas also has an interactive 2D viewer and addition-
ally provides the user with access to 3D rendered models of
labeled segmented structures produced from the single 2Dslices (segmentation routines can be reviewed on the 2D
viewer). Anatomical information and links to other relevant
web sites are also provided.
The current MR microscopy brain atlases are based on
a single brain specimen, and a probabilistic mouse brain
atlas is not yet available. Further, only one mouse strain is
represented (C57BL6/J). Obviously, multiple mice strains
exist each of which might express subtle unique anatomical
features. Another issue is whether the atlas template should
be produced from in vivo or in vitro specimens. Probably,
the best solution will be to have available in vivo as well
as in vitro templates as histologically processed brain sec-
tions are best mapped into an in vitro template, while otherdata requires in vivo templates. There is no doubt that web
based neuroinformatics tools for mice brain data are rapidly
developing. Several multi-disciplinary research groups are
currently working on different parts of the neuroinformatics
puzzlethe anatomists and neuroimagers are focusing on
the atlas templates and the computer scientists on the map-
ping algorithms, data bases and query mechanisms. Thus, in
the near future it will unquestionably be possible to routinely
access web based rodent brain atlases in a fully functional
neuroinformatics format as defined in the original mission
statement (http://www.nimh.nih.gov/neuroinformatics/).
3.3. Anatomical phenotyping by MR microscopy
The term anatomical phenotyping refers here to a char-
acterization of the observable anatomy in a given structure
or organism. Lately, there has been an ongoing and fo-
cused debate on the topic of how to develop high resolu-
tion imaging technologies into phenotypic screening tools of
transgenic and knockout mice models (NIH, 1999; see also
http://birn.ncrr.nih.gov/birn/). For the MR microscopy tech-
nology, the general idea is to acquire 3D data sets of a given
transgenic or knockout mouse and rapidly determine if the
genetic manipulation has caused any anatomical changes.
The scientific desire to streamline high resolution imaging
technologies for this particular purpose has high priority for
many reasons. First, when a given transgenic mouse, targeted
mutation or chemically induced mutation in mice are engi-
neered, the purpose most often is to create an animal model
of a given human disease or to find out what phenotype a
particular gene is responsible for. Conventional phenotypic
studies can take a long time, and it is not unusual that a given
mutation does not alter the phenotype. For the molecular bi-
ologists and bioengineers, therefore, it becomes important to
have available screening tools to rapidly determine whether
the desired pathologyor any pathology for that matter
http://www.hms.harvard.edu/research/brainhttp://mouseatlas.caltech.edu/http://birn.ncrr.nih.gov/birnhttp://www.nimh.nih.gov/neuroinformaticshttp://mouseatlas.caltech.edu/http://www.loni.ucla.edu/http://www.hms.harvard.edu/research/brain8/7/2019 Microscopic MRI
14/28
406 H. Benveniste, S. Blackband / Progress in Neurobiology 67 (2002) 393420
is present in the mouse model. Current screening tools in-
clude behavioral testing and conventional histology. Behav-
ioral testing is probably one of the most frequently used
modalities for defining phenotypes in genetically engineered
animals. By defining abnormal behaviors in transgenic or
knockout mice scientists have a measure of the phenotype
towards which a given hypothesis can be tested. Behavioraltesting requires expertise and considerable experience. In a
recent book on behavioral phenotyping of transgenic and
knockout mice it was stated that scientists are best advised
to seek training or collaboration with a good behavioral
neuroscience laboratory rather than set up the behavioral
tasks independently (Crawley, 2000). Thus, there are mul-
tiple pitfalls and false negatives/positives in behavioral as-
says and some scientists, therefore, view behavioral testing
to be too complex and/or time-consuming. The latter issue
is obviously essential to the pharmaceutical and biotechnol-
ogy industry. Conventional histological techniques are inva-
sive, often cumbersome and do not allow the investigator to
follow the onset, progression and/or regression of relevantpathology over time in the same animal. Regardless, in the
ideal world behavioral testing should routinely be combined
with a non-invasive measure of structure (and/or function) in
order to characterize a given phenotype in depth (as exam-
ples, see studies by Virley et al., 2000; Reese et al., 2000).
For any high resolution imaging technology to become
the perfect tool for anatomical screening, it needs to fulfill
the following criteria: (a) provide superior anatomical de-
tail of any given structure at least at the micro-anatomical
resolution range, (b) fast data acquisitions, (c) efficient
and low-risk animal throughput (many animals need to be
screened within a given time period with minimal morbidity
Table 3
Examples of morphological phenotyping in rodents by MR microscopy
Species/strain Magnetic
field (T)
Spatial
resolution (mm3)
Disease model Pathology detected Reference
Rattus/SpragueDawley 4.7 0.027 (in vivo) Prolactinoma Pituitary hypertrophy Rudin et al. (1999),
van Nesselrooij et al.
(1989)
Rattus/Lewis 7 8 104 (in vitro) Experimental allergic
encephalomyelitis
MS lesions Lanens et al. (1994)
Cheirogaleids/dwarf
and mouse lemurs
11.7 3 105 (in vitro) Aging Iron accumulation Gilissen et al. (1998)
Homozygous,
heterozygous AGA
and C57Bl6/J mice
1.5 6 103 (In vivo) Lysosomal storage disease:
Aspartylglucosaminuria
Enlarged ventricle
system; cerebral
atrophy
Tenhunen et al. (1998)
11.7 3 105 (in vitro) Experimental allergic
encephalomyelitis/multiple
sclerosis
MS lesions Ahrens et al. (1998a)
AnkyrinB(/) and
AnkyrinB (+/+) mice
7.1 1.2 104 (in vitro) Mental retardation,
hydrocephalus
Enlarged ventr.,
stenosis of the
aqueduct
Scotland et al. (1998)
Mouse/C57Bl6/J/male 7.1 1.6 103 (in vivo) Transient global
cerebral ischemia
Enlarged ventr.,
hippocampal atrophy
McDaniel et al. (2001)
Mouse/SJL/NBOM 1.5 ? (in vivo) Herpes simplex virus
encephalitis
Contrast-enhanced
lesions on T1-
weighted MRIs
Meyding-Lamade et al.
(1998)
and mortality) and (d) the user needs to be able to rapidly
extract relevant information from the data. Clearly, MR
microscopy is able to visualize an abundance of anatomi-
cal structures within any given organism/body organ albeit
not all. MR hardware (e.g. high-field magnets, rf coils)
(Hurlston et al., 1999; Miller et al., 1999) and development
of time-efficient pulse sequences have enabled rapid acqui-sition of 3D data sets at high spatial resolution (Suddarth
and Johnson, 1991). In the future, special hardware will be
designed that enable high-quality MR imaging of several ro-
dents at a time (Henkelman et al., 1987). We will soon learn
whether such efforts will provide consistent high-quality
data output. Another important issue to be solved in regards
to multi-animal imaging is the implementation of physi-
ological monitoring, cardiac gating and scan-synchronous
ventilation. Finally, the access to computational tools and
algorithms that allows the user to extract relevant data from
the 3D data sets is far from being available.
Although the literature is still sparse with reports on
the use of MR microscopy for anatomical phenotyping, itis nevertheless increasing (cf. Table 3). Fig. 8 shows how
MR microscopy was used to anatomically phenotype the
AnkyrinB/ neonatal mice brain in vitro (Scotland et al.,
1998).
3.3.1. Morphometry
In Section 3.3, we reviewed the literature on anatomical
phenotyping by MRI in animal models of human diseases.
In most of these studies (cf. Table 3), the discovered pathol-
ogy on the MR images was converted into a quantitative
measurefor example, an enlarged ventricle system, hy-
pertrophy or atrophy. The techniques used in these studies
8/7/2019 Microscopic MRI
15/28
H. Benveniste, S. Blackband / Progress in Neurobiology 67 (2002) 393420 407
Fig. 8. An example of anatomical phenotyping using in vitro MR microscopy is demonstrated. Volume-rendered 3D diffusion-weighted images of a
formalin-perfusion fixed normal brain (EF5 +/+) and a knockout mouse brain (AnkyrinB/, EF8/) are shown. Several anatomical structures can be
identified (yellow arrows). The presence of hydrocephalus (enlarged lateral ventricles) can be observed in the 3D image of the knockout mouse brain.
for measurement of the size and shape of biological struc-
tures was based primarily on manual segmentation. By
segmentation we mean the operation whereby contours
are constructed to partition, for example, the rodent brain
into structures of interest. These regions are typically con-structed manually according to quasi-objective criteria re-
lating to signal intensity transitions, which can be difficult
particularly in three dimensions. The concept of automated
segmentation has become increasingly important with the
now large volume of MR microscopy data being generated
from genetically engineered animals. It is now essential that
this type of data be both rapidly and accurately analyzed.
The accuracy becomes even more of an issue given the fact
that anatomical changes in genetically engineered mice can
be extremely subtle and barely detectable with less sensitive
techniques such as manual segmentation. Improved SNR
and CNR in MR microscopy images will enable possible
use of automated segmentation software in the future.
4. Pathology visualized by MR microscopy
4.1. Stroke
The use of MR microscopy, or at least high resolution
MRI, for detection of stroke was an obvious research appli-
cation given the ability of the technology to visualize the
high concentration of proton-rich water . . . in biological
systems (Buonanno et al., 1982, 1983; Levy et al., 1983;
Mano et al., 1983; Brant-Zawadzki et al., 1985). Thus due
to a higher than normal water content within ischemic brain
tissue secondary to the presence of vasogenic edema the
infarct would theoretically be apparent on, for example,
proton density-weighted MR images. Buonanno et al. werethe first to provide the proof of principle in regards to ac-
tually demonstrating ischemic brain tissue non-invasively
by MR imaging (Buonanno et al., 1982, 1983). In one of
the earliest experiments, serial proton density-weighted MR
images were acquired in gerbils after unilateral occlusion of
the common carotid artery and areas of increased signal in-
tensity were demonstrated within the occluded hemisphere
as early as 2 h after ischemia onset (Buonanno et al., 1983).
Corresponding spectroscopy data on the excised ischemic
tissue revealed elevated T1 and T2 relaxation times when
compared to non-ischemic control tissue (Buonanno et al.,
1983). Over the last two decades, numerous scientific re-
ports have appeared on the topic of MRI and stroke. In an
attempt to briefly review this plentiful literature in a sys-
tematic fashion, we have divided it into three major topics:
(a) diagnostic studies, (b) pathophysiological studies and
(c) studies testing therapeutic interventions.
4.1.1. Diagnostic studies
MR microscopy provided researchers with a mean to
non-invasively detect the presence of an ischemic infarct
or stroke in the brain of the living animal. This capabil-
ity was a unique revelation to neuroscientists because for
the first time it was possible to study the phenomenon of
8/7/2019 Microscopic MRI
16/28
408 H. Benveniste, S. Blackband / Progress in Neurobiology 67 (2002) 393420
stroke maturation as it occurred andat least theoretically
follow the effect of therapeutic interventions in a much more
aggressive manner than was permitted by neurological ex-
ams alone. The first efforts used proton density, T1- and
T2-weighted MR microscopy, to detect and characterize the
progression of focal ischemic lesions (Buonanno et al., 1982,
1983; Levy et al., 1983; Mano et al., 1983; Brant-Zawadzkiet al., 1985; Horikawa et al., 1986; Kato et al., 1986; Naruse
et al., 1986) and global transient cerebral ischemia (Iwama
et al., 1992). Major conclusions from these first studies were
as follows: (1) ischemic brain tissue could be visualized on
T1- and T2-weighted MR images 24h after onset of stroke
(Buonanno et al., 1983; Levy et al., 1983; Mano et al., 1983;
Brant-Zawadzki et al., 1985), (2) signal changes on T1- or
T2-weighted images and significant increases in T1 and T2
relaxation times occurred only in neurologically affected
animals suggesting diagnostic specificity (Buonanno et al.,
1983; Levy et al., 1983) and (3) the area of signal change on
T1- and T2-weighted MR images induced by ischemia cor-
related with histological evidence of necrosis at late (>16 h)post-ischemic time points (Buonanno et al., 1983; Levy
et al., 1983; Brant-Zawadzki et al., 1985).
Diagnostic stroke studies took another step for-
ward in 1990 when Moseley et al. discovered that
diffusion-weighted MR imaging was far more sensitive
than T1- and T2-weighted MR imaging in detection of
ischemic brain tissue (Moseley et al., 1990a,b). Thus,
diffusion-weighted images displayed a significant hyperin-
tensity in ischemic brain regions as early as 45 min after
onset of the stroke in cat brains (Moseley et al., 1990a).
This result was later confirmed in experimental focal is-
chemia models in rats (Knight et al., 1991, 1994; MacFallet al., 1991; Mintorovitch et al., 1991; Benveniste et al.,
1992; Minematsu et al., 1992; van Bruggen et al., 1992;
Verheul et al., 1992; Lo et al., 1994) and mice (Zaharchuk
et al., 1997; Hata et al., 1998; van Bruggen et al., 1999). In
contrast to the rapid demarcation of the ischemic territory
in stroke models, it apparently takes several days for signal
changes to appear on diffusion-weighted MR brain images
after transient cerebral global ischemia in rats (Kawahara
et al., 2000). Similarly, in C57BL6/J mice exposed to tran-
sient global forebrain ischemia signal intensity changes
on diffusion-weighted MRIs were observed three days
post-ischemia, but only in areas with profound necrosis
(McDaniel et al., 2001). Interestingly, the ischemia-induced
signal increases on diffusion-weighted MR images seemed
to be specific for brain tissue because it did not occur simul-
taneously in the adjacent temporal muscle (MacFall et al.,
1991).
In the focal ischemia models, it was noted that the lesion
expanded over time (Lo et al., 1994; Roussel et al., 1994;
Hall et al., 1996) and that the growth was caused by
peri-infarct depolarizations (Hasegawa et al., 1995; Busch
et al., 1996; Rother et al., 1996). Fig. 9 shows expansion
of a stroke lesion in rat brain following occlusion of the
middle cerebral artery (MCA). The diffusion-weighted im-
ages shown in Fig. 9 were acquired at 6 and 21 h following
MCA occlusion, and it is clear that the high signal intensity
area has enlarged over the 13 h ischemia time period. Again
other studies have shown that signal changes induced by is-
chemia on diffusion-weighted MR images can be reversed if
the ischemic episode is limited (Mintorovitch et al., 1991).
However, reversal of ischemia-induced diffusion changesdoes not necessarily signify that histologic normalization
has occurred (Miyasaka et al., 2000).
A series of T2- and diffusion-weighted MR microscopy
experiments were performed in rats at various times after
stroke onset and correlated with histopathology (Jiang et al.,
1997). From these and other studies, a model of dual pa-
rameter MRI analysis was developed, which could be used
to predict the state of tissue damagetheoretically at any
given time point following stroke onset (Welch et al., 1995;
Jiang et al., 1997; Virley et al., 2000). Further refine-
ment of the multi-parameter MRI analysis in predict-
ing tissue damage also referred to as tissue signature
modeling for classification of ischemic tissue damagewas recently undertaken by Jacobs et al. who imple-
mented an unsupervised segmentation method cluster
analysis algorithm (Jacobs et al., 2000). This tech-
nique was shown to accurately identify ischemic cell
damage both early and later after stroke onset (Jacobs
et al., 2000).
4.1.2. MR microscopy studies related to stroke
pathophysiology
What exactly do ischemia-induced signal changes on
T1-, T2- and diffusion-weighted MR images reflect in
pathophysiological terms? For neuroscientists and neurol-ogists this is obviously an extremely important question to
address in order to successfully implement the diagnostic
capabilities of MRI in the treatment of stroke in humans.
How else can clinicians correctly interpret signal changes
in the course of therapy? By understanding in detail the un-
derlying pathophysiology for a given MR parameter change
in the course of stroke evolution, we will learn how and
when it is possible to intervene and when it is too late.
The mechanism of stroke detection by proton density-
weighted MR imaging was straightforwardly explained as a
consequence of a higher than normal water content within
the infarcted area (Buonanno et al., 1983; Levy et al., 1983;
Horikawa et al., 1986; Naruse et al., 1986). However, the
pathophysiological mechanisms underlying corresponding
changes in T1 and T2 relaxation times were more diffi-
cult to define. It became clear that T1 and T2 changes in
ischemic tissue were delayed by 24 h after stroke onset
(Buonanno et al., 1983; Horikawa et al., 1986; Kato et al.,
1986) and corresponded to the lag in vasogenic edema for-
mation (Horikawa et al., 1986). It was also demonstrated
that T2 relaxation times increased quantitatively more
than T1 relaxation times after ischemia onset (Kato et al.,
1986), and T2-weighted imaging sequences were, there-
fore, more time sensitive to detection of ischemic tissue
8/7/2019 Microscopic MRI
17/28
H. Benveniste, S. Blackband / Progress in Neurobiology 67 (2002) 393420 409
Fig. 9. Diffusion-weighted MR images from rat brain acquired in vivo at 6 h (top) and 21 h (bottom) following occlusion of the middle cerebral artery. The
stroke can be recognized as a high signal intensity area (arrows) located in the frontal and parietal cortices at 6 h. It is clear that the ischemia-induced
high signal intensity area has enlarged and intensified over the 12 h period.
(Kato et al., 1986). Kato et al. found superior quantitative
correspondence between ischemia-induced areas of high
signal intensity on T1- and T2-weighted MR images and
areas of potassium depletion but not with areas of ATPase
reductions (Kato et al., 1986). Interestingly, when T1 and
T2 relaxation times measured in ischemic brain tissue were
plotted against corresponding values of tissue water con-
tent, T1 was found to be linearly dependent on it whereas
T2 values were not (Kato et al., 1986; Kamman et al.,
1988; Venkatesan et al., 2000). Thus, the increase in T2 by
ischemia could not be explained on the basis of water con-
tent alone (Kato et al., 1986) and it was suggested to be an
effect of protein content alterations (Kamman et al., 1988).
A more extensive analysis of relaxation times in edematous
tissue by Naruse et al. further revealed that the T2 decay con-
sisted of two time components in ischemic tissuea fast and
a slow componentand only one in normal tissue (Naruse
and Hirakawa, 1986; Naruse et al., 1986). The fast compo-
nent presumably reflected the intracellular fraction and
the slow component the extracellular fraction (Naruse
and Hirakawa, 1986; Naruse et al., 1986). In ischemic tis-
sue, the T2 values of the extracellular fraction were lower
than that of the intracellular fraction because of accumula-
tion of protein-rich edema fluid, which over time restricted
movement of water molecules in this compartment (Naruse
and Hirakawa, 1986; Naruse et al., 1986).
In regards to diffusion-weighted imaging, the pathophys-
iological mechanisms behind stroke detection are more ap-
parent. First, significant correlation was found between the
early ischemia-induced diffusion-weighted signal intensity
changes and alterations in Pii:PCr and lactate:NAA peak
area ratios (Moseley et al., 1990a,b). It was suggested, there-
fore, that the hyperintensity on diffusion images represented
disturbances of the intracellular energy metabolism and thus
could possibly serve as a more specific diagnostic tool of
the ischemia process itself (Moseley et al., 1990a,b). In sup-
port of this statement, it was shown that the signal started to
increase on diffusion-weighted images when cerebral blood
flow (CBF) was reduced to 1520 cm3/(100 g min) in gerbil
brains (Busza et al., 1992; Mancuso et al., 1995).
8/7/2019 Microscopic MRI
18/28
410 H. Benveniste, S. Blackband / Progress in Neurobiology 67 (2002) 393420
Moseley et al. also suggested that the ischemia-induced
apparent diffusion coefficient (ADC) decrease was due to
intracellular swelling (cytotoxic edema) during which wa-
ter protons originally in the faster-diffusing extracellular
space migrate into a more diffusion-restricted intracellu-
lar compartment (Moseley et al., 1990a,b). In favor of
this hypothesis, it was later shown that cytotoxic edemainduced in the living brain with ouabain known to arrest
Na+K+ ATPase also produced a decrease in the ADC
similarly to that induced by ischemia (Benveniste et al.,
1992). This was also observed under more controlled con-
ditions in the isolated perfused rat hippocampal brain slice
(Buckley et al., 1999b). Similarly, other pathophysiological
processes known to cause cytotoxic cell swelling, such as
excitotoxins (King et al., 1991; Benveniste et al., 1992;
Verheul et al., 1993, 1994; Dijkhuizen et al., 1996; Black-
band et al., 1999), cortical spreading depressions (Latour
et al., 1994; Hasegawa et al., 1995; Busch et al., 1996)
and cardiac-arrest induced anoxic depolarizations (Davis
et al., 1994; de Crespigny et al., 2001) also reduce theADC. Interestingly, within 1020 s of cardiac arrest there
is an immediate 5% ADC decrease, which is attributed to
the cessation of vascular spin motion (de Crespigny et al.,
2001). All the above mentioned diffusion imaging experi-
ments have served to partly clarify the diagnostic potential
of diffusion-weighted MRI and made it clear that if used
for stroke diagnostic purposes diffusion imaging needs to
be combined with other imaging modalities (e.g. perfusion,
spectroscopy) in order to obtain adequate information.4
4.1.3. Therapeutic stroke studies
Therapeutic interventional studies with various com-pounds in experimental stroke models have been performed
using diffusion- and T2-weighted MR microscopy (recently
reviewed by Rudin et al., 1999). The strength of these stud-
ies in comparison with those using conventional histology
as an endpoint are (1) the animals can be used as their own
control and (2) progression and/or regression of stroke mat-
uration can be followed over time in the same animal. Both
of these features increase statistical power and theoretically
reduce the number of animals used in a given study (Hall
et al., 1996). For example, Shi et al. have demonstrated the
neuroprotective effect of estrogen in a rat model of stroke
as evidenced by a reduction in the infarct volume (Shi et al.,
2001). For further information on therapeutic intervention
studies, the reader is referred to a recent review article
(Rudin et al., 1999).
4 Several alternate hypotheses underlying the ischemia-induced ADC
decrease have been proposed, tested and partly rejected. For instance,
early ADC reductions in ischemic tissue were attributed to cell membrane
permeability changes, restricted diffusion and/or increased tortuosity in
the extracellular space (for in-depth reviews on these topic the reader is
referred to recent review articles (Blackband et al., 1999; Duong et al.,
2001; Gass et al., 2001).
4.2. Head injury
Diffusion-weighted MR microscopy has been used to
follow the progression of acute and chronic head injury in ro-
dents (Hanstock et al., 1994; Assaf et al., 1997, 1999; Barzo
et al., 1997). Similar to ischemia, signal intensity increases
acutely within the injured brain area on diffusion- (Hanstocket al., 1994; Assaf et al., 1997, 1999) and T2-weighted MR
images indicating the presence of both vasogenic and cyto-
toxic edema (Assaf et al., 1997). However, 7 days following
closed head injury the signal becomes hypointense and the
ADC quantitatively approaches that of free water probably
reflecting tissues in which a large population of cells have
been disrupted (Assaf et al., 1997). In a recent study, closed
head injury was induced in 30 g mice and a neuroprotective
agent (NAPSVIPQ, a femtomolar-acting peptide) was ad-
ministered subcutaneously after the insult (Beni-Adani et al.,
2001). T2-weighted MR microscopy demonstrated signif-
icant brain-tissue recovery in the treated mice at 2 weeks
and also reduced overall mortality (Beni-Adani et al.,
2001).
To investigate the role of endogenous apolipoprotein E
(ApoE) in closed head injury MR microscopy was performed
on ApoE knockout mice (ApoE/) and control 24 h after
the insult (Lynch et al., 2002). The degree of lateral ventri-
cle effacement was used as an indirect measure of edema
(cf. Fig. 10) and quantitative analysis demonstrated that
ApoE/ mice developed more edema than C57BL6/J mice
(Lynch et al., 2002). Interestingly, the amount of edema also
correlated with increased brain production of tumor necro-
sis factor-, a pro-inflammatory cytokine believed to play
an important role in mediating BBB breakdown and devel-opment of cerebral edema (Lynch et al., 2002).
4.3. Demyelinating diseases
No naturally occurring disease of the central nervous sys-
tem in animals is known that corresponds to multiple scle-
rosis (MS). However, experimental animal models, which
result in demyelination and formation of plaque-like areas
of inflammation, are instead available to researchers study-
ing MS. The most frequently used animal model is the
so-called experimental allergic encephalomyelitis (EAE)
induced in animals by sensitizing them to components of
central myelin. EAE lesions have been demonstrated in vitro
in the rat spinal cord at a spatial resolution of 8104 mm3
(Lanens et al., 1994) and in mice spinal cords at 2.7 105 mm3 (Ahrens et al., 1998a). EAE-induced plaque-like
lesions were also demonstrated in vivo in a EAE SJL mouse
model at a spatial resolution of 3.4 103 mm3 by in-
jecting contrast (monocrystalline iron oxide nanoparticle,
MION-46) intravenously (Xu et al., 1998). In this study,
EAE lesions were visualized as a central punctuate area
of hypointensity surrounded by hyperintensity (Xu et al.,
1998). The hypointensity was interpreted as an effect of ex-
travasation of the contrast agent due to blood brain barrier
8/7/2019 Microscopic MRI
19/28
H. Benveniste, S. Blackband / Progress in Neurobiology 67 (2002) 393420 411
Fig. 10. Volume-rendered 3D diffusion-weighted MR image from a C57Bl6/J mouse acquired in vivo 24 h following closed head injury. The closed head
injury impact area can be recognized as a high signal intensity zone (arrow), which has caused effacement of the ipsi-lateral ventricle.
breakdown in the area of the EAE lesion (Xu et al., 1998).
It is clear that the use of contrast agents facilitates visualiza-tion of EAE lesions at least acutely and several experimen-
tal contrast agents are being tested for this purpose (see also
Sipkins et al., 2000). In another experimental animal model,
lysophospahtidylcholine (LPC) was injected directly into the
internal capsule in rats to produce localized demyelinating
lesions, which were visible 48 h after the injection on both
T1- and T2-weighted MR microscopy images at a spatial
resolution of 0.16 mm3 (Ford et al., 1990).
Interestingly, the process of myelination has also been
studied using MR microscopy (Bulte et al., 1999). Rat
oligodendrocyte progenitor cells were first labeled with
MION-46L nanoparticles using specific transferrin receptor
targeting techniques (see, for detailed reviews, Bogdanov
et al., 2000; Weissleder et al., 2000; Wunderbaldinger et al.,
2000). The labeled cells were subsequently grafted in to the
spinal cord of neonatal myelin-deficient rats (Bulte et al.,
1999). Ten days later, the spinal cord was removed and
imaged in vitro. The MR microscopy images demonstrated
extensive migration of the grafted cells, particularly in the
area of the dorsal column (Bulte et al., 1999). This study
introduces MR microscopy as a technique to track the
migratory capacity of magnetically labeled cells after trans-
plantation and holds promise for future studies involving
the general processing involved in neurografting.
4.4. Aging and dementia
One of the hallmarks of aging in the brain is atrophy ( Esiri
et al., 1997). Development of cerebral atrophy in brains of
mouse lemur primates (Dhenain et al., 2000), C57BL6/J
mice and ApoE/ mice (McDaniel et al., 2001) can be
tracked non-invasively by MR microscopy. In Dhenains
study, mouse lemur primates were followed for up to 2 years
and T2-weighted images (spatial resolution of 0.05 mm3)
were acquired two to three times in each animal at various
time points (Dhenain et al., 2000). Global atrophy was es-
timated by measuring total CSF volume and in most of the
animals it increased with aging. Interestingly, four out of the
seven oldest animals did not display atrophy even at very
advanced ages (Dhenain et al., 2000).
In mice brains, development of forebrain atrophy was
indirectly assessed by measuring the ventricle volumes
on diffusion-weighted MR microscopy images before and
30 days after exposure to transient forebrain ischemia
(McDaniel et al., 2001). Thus, the animals served as their
own control, and the analysis showed that ventricle vol-
ume increased significantly in both C57BL6/J and ApoE
deficient mice (McDaniel et al., 2001). Fig. 11 displays the
significant volume increase particularly in the lateral ven-
tricles, which occurs following transient cerebral ischemia
in the C57BL6/J mouse brain.
8/7/2019 Microscopic MRI
20/28
412 H. Benveniste, S. Blackband / Progress in Neurobiology 67 (2002) 393420
Fig. 11. Brain atrophy can be tracked in the mouse brain by in vivo MR microscopy. Two volume-rendered diffusion-weighted MR images from a
C57Bl/6 mouse brain are shown acquired before and 30 days after a 10-min period of transient cerebral ischemia. The ventricles are outlined (filled-in
space) on the volume-rendered images and it is evident that the lateral ventricles have enlarged as a consequence of ischemia-induced brain atrophy.
In another study, brains of very old (15 years old) and
younger mouse lemurs were examined using T2-weighted
MR microscopy and compared with subsequent histologi-
cal processing for iron content (Gilissen et al., 1998). The
T2-weighted images revealed dark regions in the areas of
the globus pallidus, the substantia nigra and the corpus cal-
losum, which corresponded to areas with high iron content(Gilissen et al., 1998). The findings of this study supported
the hypothesis that brain iron (ferritin) is the primary de-
terminant of MRI contrast and that iron accumulates in the
normal aging brain (Gilissen et al., 1998).
Until now, only preliminary reports are available on the
characterization of neuropathology in genetically engineered
mouse models of Alzheimers disease (AD) (Helpern et al.,
2001; Zhang et al., 2001). Preliminary data suggest that brain
atrophy does not develop over time neither in the PDAPP
transgenic AD mouse model (Zhang et al., 2001) nor in the
PS-APP transgenic AD mouse model (Helpern et al., 2001).
Additionally, the ventricle system in PDAPP mice appears
highly abnormal compared to normal control mice (Zhang
et al., 2001). More information on MRI characteriza-
tions of genetically engineered mouse models of AD
will undoubtedly appear in the literature in the very near
future and clarify the significance of using these mod-
els in the study of the equivalent clinical condition in
humans.
4.5. MR microscopy of brain tumors in rodents
The non-invasive approach to detection and the capabil-
ity of obtaining volumetric quantitative information makes
MRI an obvious tool for a broad range of experimental
cancer studies. Thus, MR microscopy has been used to
(1) characterize the appearance of tumors using various
MR parameters, (2) follow tumor growth in small animals
(Damadian et al., 1976; Crooks et al., 1980; Hansen et al.,
1980; Davis et al., 1981; Henkelman et al., 1987; Rajan
et al., 1990; Lemaire et al., 2000) and (3) follow the effectof treatment (Benedetti et al., 2000; Roy et al., 2000).
Contrast agents are known to enhance MR visualization
of various types of intracranial tumors secondary to the pres-
ence of abnormal vessels within the tumor tissue (Runge
et al., 1988; Norman et al., 1989; Bockhorst et al., 1990;
Wilmes et al., 1993; Hoehn-Berlage and Bockhorst, 1994;
Moore et al., 2000; Fonchy et al., 2001). Fig. 12 shows
how administration of a contrast agent can enhance the
definition of tumor tissue on T1-weighted MR microscopy
images. Some contrast agents when given intravenously or
intraperitoneally will provide enhanced tumor visualization
on T1- and T2-weighted MR images for several hours fol-
lowing administration (Wilmes et al., 1993; Ikezaki et al.,
1994a,b; Moore et al., 2000), while others only provide
enhancement for brief, transient intervals (Hoehn-Berlage
and Bockhorst, 1994). For example, in tumor-bearing ro-
dents an intra-peritoneal injection of Gd-DTPA caused
various tumor-associated tissue compartments to appear
transiently on T1-weighted MR images in a characteristic
time-dependent manner (Hoehn-Berlage and Bockhorst,
1994): first the tumor became apparent, later centrally lo-
cated cysts and peritumoral edema (Hoehn-Berlage and
Top Related